ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies - Texts

Home
Main Navigation
Content
Search
Help

Font Standard Bold
Login

Research unit

INNOSUISSE

Project number

61685.1 IP-LS

Project title

ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101.951 IP-LS)

Texts for this project

	German	French	Italian	English
Short description		-	-
Abstract		-	-	-

Inserted texts

Category	Text
Short description (German)	ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies (Innolink: 101.951 IP-LS)
Short description (English)	ONCONIX: A revolutionary organoid culturing and drug efficacy testing platform for personalized response prediction to cancer therapies
Abstract (German)	We will deliver ONCONIX: a highly innovative personalized treatment-response prediction platform for oncology based on uniquely rapid patient-derived organoid cultures and in-house developed machine learning models. Here, we will perform a non-interventional proof-of-concept study in bladder cancer.